• Users Online: 302
  • Print this page
  • Email this page
BRIEF REPORT
Year : 2022  |  Volume : 5  |  Issue : 3  |  Page : 199-203

Coronavirus disease 2019 in patients with sickle cell disease: A cross-sectional study from Jazan Province, Saudi Arabia


Faculty of Medicine, Jazan university, Jazan 45142, Saudi Arabia

Correspondence Address:
Abdulaziz Alhazmi
Microbiology and Parasitlogy department, Faculty of Medicine, Jazan university, Al Maarefah Rd, Jazan 45142
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jnsm.jnsm_49_21

Rights and Permissions

Objectives: To assess the prevalence of coronavirus disease 2019 (COVID-19) infection among sickle cell disease (SCD) patients in Jazan region and to determine the impact of COVID-19 on the SCD population. Methods: This was an observational, descriptive, cross-sectional study using a self-administrated questionnaire directed to SCD patients in Jazan to assess the prevalence of COVID-19. The data were analyzed using a t-test and Chi-square test. Results: A total of 188 responses were received and only 96 SCD patients were included (mean age is 24 years). About half of the study samples (53%) of the study population were male. About 11% of patients with SCD were diagnosed with COVID-19. Vaso-occlusive crisis was reported in 73% and a single patient presented with acute chest syndrome. About three-fourths of patients (73%) were admitted to the hospital and most of them experienced mild symptoms and one patient was treated in the intensive care unit. Conclusion: SCD patients are at risk of SARS-CoV-2 infection. In the absence of comorbidities, patients with SCD are not at increased risk of COVID-19 mortality, but a higher admission rate is reported. SCD patients with COVID-19 may have a milder clinical course, compared to other populations with comorbidities such as diabetes and hypertension, and this may be due to proinflammatory adaptation of the immune system. Larger studies including epidemiological and molecular details are needed to enhance our understanding of how SARS-CoV-2 could affect patients with SCD.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed650    
    Printed30    
    Emailed0    
    PDF Downloaded78    
    Comments [Add]    

Recommend this journal